Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans

Frank R Sharp, Glen C. Jickling, Boryana Stamova, Yingfang Tian, Xinhua Zhan, Da Liu, Beth Kuczynski, Christopher D. Cox, Bradley Ander

Research output: Contribution to journalReview article

48 Citations (Scopus)

Abstract

Whole genome expression microarrays can be used to study gene expression in blood, which comes in part from leukocytes, immature platelets, and red blood cells. Since these cells are important in the pathogenesis of stroke, RNA provides an index of these cellular responses to stroke. Our studies in rats have shown specific gene expression changes 24 hours after ischemic stroke, hemorrhage, status epilepticus, hypoxia, hypoglycemia, global ischemia, and following brief focal ischemia that simulated transient ischemic attacks in humans. Human studies show gene expression changes following ischemic stroke. These gene profiles predict a second cohort with 90% sensitivity and specificity. Gene profiles for ischemic stroke caused by large-vessel atherosclerosis and cardioembolism have been described that predict a second cohort with 85% sensitivity and specificity. Atherosclerotic genes were associated with clotting, platelets, and monocytes, and cardioembolic genes were associated with inflammation, infection, and neutrophils. These gene profiles predicted the cause of stroke in 58% of cryptogenic patients. These studies will provide diagnostic, prognostic, and therapeutic markers, and will advance our understanding of stroke in humans. New techniques to measure all coding and noncoding RNAs along with alternatively spliced transcripts will markedly advance molecular studies of human stroke.

Original languageEnglish (US)
Pages (from-to)1513-1531
Number of pages19
JournalJournal of Cerebral Blood Flow and Metabolism
Volume31
Issue number7
DOIs
StatePublished - 2011

Fingerprint

Stroke
RNA
Genes
Gene Expression
Blood Platelets
Ischemia
Sensitivity and Specificity
Untranslated RNA
Status Epilepticus
Transient Ischemic Attack
Hypoglycemia
Monocytes
Atherosclerosis
Neutrophils
Leukocytes
Erythrocytes
Genome
Hemorrhage
Inflammation
Infection

Keywords

  • brain
  • gene expression profiling
  • ischemia
  • microarrays

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Molecular markers and mechanisms of stroke : RNA studies of blood in animals and humans. / Sharp, Frank R; Jickling, Glen C.; Stamova, Boryana; Tian, Yingfang; Zhan, Xinhua; Liu, Da; Kuczynski, Beth; Cox, Christopher D.; Ander, Bradley.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 31, No. 7, 2011, p. 1513-1531.

Research output: Contribution to journalReview article

Sharp, Frank R ; Jickling, Glen C. ; Stamova, Boryana ; Tian, Yingfang ; Zhan, Xinhua ; Liu, Da ; Kuczynski, Beth ; Cox, Christopher D. ; Ander, Bradley. / Molecular markers and mechanisms of stroke : RNA studies of blood in animals and humans. In: Journal of Cerebral Blood Flow and Metabolism. 2011 ; Vol. 31, No. 7. pp. 1513-1531.
@article{348bb4408b2e4d98869222e9becaa463,
title = "Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans",
abstract = "Whole genome expression microarrays can be used to study gene expression in blood, which comes in part from leukocytes, immature platelets, and red blood cells. Since these cells are important in the pathogenesis of stroke, RNA provides an index of these cellular responses to stroke. Our studies in rats have shown specific gene expression changes 24 hours after ischemic stroke, hemorrhage, status epilepticus, hypoxia, hypoglycemia, global ischemia, and following brief focal ischemia that simulated transient ischemic attacks in humans. Human studies show gene expression changes following ischemic stroke. These gene profiles predict a second cohort with 90{\%} sensitivity and specificity. Gene profiles for ischemic stroke caused by large-vessel atherosclerosis and cardioembolism have been described that predict a second cohort with 85{\%} sensitivity and specificity. Atherosclerotic genes were associated with clotting, platelets, and monocytes, and cardioembolic genes were associated with inflammation, infection, and neutrophils. These gene profiles predicted the cause of stroke in 58{\%} of cryptogenic patients. These studies will provide diagnostic, prognostic, and therapeutic markers, and will advance our understanding of stroke in humans. New techniques to measure all coding and noncoding RNAs along with alternatively spliced transcripts will markedly advance molecular studies of human stroke.",
keywords = "brain, gene expression profiling, ischemia, microarrays",
author = "Sharp, {Frank R} and Jickling, {Glen C.} and Boryana Stamova and Yingfang Tian and Xinhua Zhan and Da Liu and Beth Kuczynski and Cox, {Christopher D.} and Bradley Ander",
year = "2011",
doi = "10.1038/jcbfm.2011.45",
language = "English (US)",
volume = "31",
pages = "1513--1531",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Molecular markers and mechanisms of stroke

T2 - RNA studies of blood in animals and humans

AU - Sharp, Frank R

AU - Jickling, Glen C.

AU - Stamova, Boryana

AU - Tian, Yingfang

AU - Zhan, Xinhua

AU - Liu, Da

AU - Kuczynski, Beth

AU - Cox, Christopher D.

AU - Ander, Bradley

PY - 2011

Y1 - 2011

N2 - Whole genome expression microarrays can be used to study gene expression in blood, which comes in part from leukocytes, immature platelets, and red blood cells. Since these cells are important in the pathogenesis of stroke, RNA provides an index of these cellular responses to stroke. Our studies in rats have shown specific gene expression changes 24 hours after ischemic stroke, hemorrhage, status epilepticus, hypoxia, hypoglycemia, global ischemia, and following brief focal ischemia that simulated transient ischemic attacks in humans. Human studies show gene expression changes following ischemic stroke. These gene profiles predict a second cohort with 90% sensitivity and specificity. Gene profiles for ischemic stroke caused by large-vessel atherosclerosis and cardioembolism have been described that predict a second cohort with 85% sensitivity and specificity. Atherosclerotic genes were associated with clotting, platelets, and monocytes, and cardioembolic genes were associated with inflammation, infection, and neutrophils. These gene profiles predicted the cause of stroke in 58% of cryptogenic patients. These studies will provide diagnostic, prognostic, and therapeutic markers, and will advance our understanding of stroke in humans. New techniques to measure all coding and noncoding RNAs along with alternatively spliced transcripts will markedly advance molecular studies of human stroke.

AB - Whole genome expression microarrays can be used to study gene expression in blood, which comes in part from leukocytes, immature platelets, and red blood cells. Since these cells are important in the pathogenesis of stroke, RNA provides an index of these cellular responses to stroke. Our studies in rats have shown specific gene expression changes 24 hours after ischemic stroke, hemorrhage, status epilepticus, hypoxia, hypoglycemia, global ischemia, and following brief focal ischemia that simulated transient ischemic attacks in humans. Human studies show gene expression changes following ischemic stroke. These gene profiles predict a second cohort with 90% sensitivity and specificity. Gene profiles for ischemic stroke caused by large-vessel atherosclerosis and cardioembolism have been described that predict a second cohort with 85% sensitivity and specificity. Atherosclerotic genes were associated with clotting, platelets, and monocytes, and cardioembolic genes were associated with inflammation, infection, and neutrophils. These gene profiles predicted the cause of stroke in 58% of cryptogenic patients. These studies will provide diagnostic, prognostic, and therapeutic markers, and will advance our understanding of stroke in humans. New techniques to measure all coding and noncoding RNAs along with alternatively spliced transcripts will markedly advance molecular studies of human stroke.

KW - brain

KW - gene expression profiling

KW - ischemia

KW - microarrays

UR - http://www.scopus.com/inward/record.url?scp=85027927887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027927887&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2011.45

DO - 10.1038/jcbfm.2011.45

M3 - Review article

AN - SCOPUS:85027927887

VL - 31

SP - 1513

EP - 1531

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 7

ER -